维普中文期刊产品整合服务
10篇 您的检索式:作者名="Modi MS"
    题名 作者 年代 出处 被引量
1Myocardial metabolic changes during pediatrie eardiae surgery : a randomized study of 3 cardioplegic techniques 显示文摘Modi P Suleiman MS Reeves B 2004J Thorac Cardiovasc Surg2004,128,1:1
2Combination of trastuzumab and tanespimycin (17-AAG,KOS -953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer:a phase Ⅰ dose-escalation study显示文摘Modi S Stopeck AT Gordon MS 2007J Clin Oncol2007,25,:1
3Combination of trastuzumab and tanespimycin (17-AAG,KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer:a phase I dose-escalation study显示文摘Modi S Stopeck AT Gordon MS 2007J Clin Oncol2007,25,34:1
4Myocardial taurine, development and vulnerability to ischemia显示文摘 Suleiman MS 2004Amino Acid2004,26,1:1
5Posterior multilevel verte- bral osteotomy tbr correction of severe and rigid neuromus- cular scoliosis :a preliminary study 显示文摘Sub SW Hitesh N Modi MS 2009Spine2009,34,12:1
6Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy 显示文摘Wyeth MS Zhang N Mody I 2010J Neurosci2010,30,26:1
7Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 eardioplegic techniques 显示文摘Modi P Suleiman MS Reeves B 2004J Thorac Cardiovase Surg2004,128,1:1
8Auaemia and the risk of injurious falls in a community-dwelling elderly population显示文摘duh MS Mody SH Lefebvre P 2008Drugs Aging2008,25,:1
9Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques显示文摘Modi P Suleiman MS Reeves B 2004J Thorac Cardiovasc Surg2004,128,:1
10Combination of trastu- zumab and tanespimycin ( 17-AAG, KOS-953 ) is safe and active in trastuzumab-refractory HER-2 - overexpressing breast cancer: a phase I dose-escalation study 显示文摘Modi S Stopeck AT Gordon MS 2007J Clin Oncol2007,25,34:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费